D.M. Wong, S.J. Simpson / Polyhedron 25 (2006) 2303–2317
2315
3J(HH) 7 Hz, NCHMe), 1.95 (br.d, 1H, 2J(HH) 11 Hz,
(0.20 g, 0.57 mmol) and excess S(À)-N-methyl-1-phenylethyl-
amine (0.25 ml, 1.72 mmol). This yellow-orange solution
was stirred in the dark at room temperature for 24 h. After
filtration and solvent removal from the filtrate under
reduced pressure, fine yellow crystals were obtained by
crystallizing the residue at À30 ꢁC from dichloromethane
and diethylether (1:3, 15 ml) overnight. Yield 0.18 g (62%).
IR (Nujol): mmax 3263w, 1585vw (NH), 2122s (CN), and
841br.s cmÀ1 (PF6). MS (FAB): 647 [M À PF6]+(11%),
511(100), 454(11), 429(38).
3
NH), 1.09 (d, 3H, J(HH) 7 Hz, CHMe) ppm. 13C{1H}
2
NMR (CD2Cl2/CDCl3): d 203.92 (d, J(PC) 19 Hz, CO),
134.34 (d, Cipso, PPh3), 133.95 (d, 2J(PC) 11 Hz, Cortho
PPh3), 132.11 (s, Cpara, PPh3), 129.92 (d, J(PC) 10 Hz,
,
3
C
meta, PPh3), 129.54 (s, Cortho, Ph), 129.12 (s, Cpara, Ph),
128.12 (s, Cmeta, Ph), 86.39 (s, C5H5), 64.19 (s, NCHPh),
25.59 (s, CHMe) ppm. 31P{1H} NMR (CD2Cl2/CDCl3):
d 55.58 (s, PPh3) ppm. MS (FAB): 578 [M À PF6]+(37%),
457(63), 429(100).
The 1H NMR spectrum of the crystals revealed four dia-
stereomers were present; integration of the cyclopentadie-
nyl ligand singlets produced a ratio of 5:20:2:25 for
SSS:SRS:RRS:RSS. Concentration of the mother-liquor
above to ca. 7 ml and cooling to À25 ꢁC gave yellow crys-
tals, yield 0.05 g. (17%), whose spectrum showed the diaste-
reomer ratio to be 5:12:2:4.
5.2.11. (SRuSC)-[(g5-C5H5)Ru(PPh3)(CNtBu)-
(NH2CHMePh)]PF6 (7SS)
The partial data was obtained from the spectra obtained
from the sample of (7RS) above.
1H NMR (CD2Cl2/CDCl3): d 7.40–7.52 and 7.27–7.34
(m, 15H, PPh3), 6.95 (m, 5H, Ph), 5.13 (s, 5H, C5H5),
3
1.39 (d, 3H, J(HH) 7 Hz, CHMe) ppm. 13C{1H} NMR
10RSS: 1H NMR (CD2Cl2): d 7.33–7.54 (m, 15H, PPh3),
7.05 (m, 5H, Ph), 4.64 (s, 5H, C5H5), 3.63 (quintet, 1H,
3J(HH) 7 Hz, NHCH), 2.29 (d, 3H, 3J(HH) 6 Hz,
(CD2Cl2/CDCl3): d 142.67 (s, Cipso, PPh3), 133.85 (d,
2J(PC) 11 Hz, Cortho, PPh3), 131.56 (s, Cpara, PPh3),
3
129.38 (d, 3J(PC) 10 Hz, Cmeta, PPh3), 127.03 (s, Cmeta
,
NHCH3), 2.05 (br.q, 1H, J(HH) 6 Hz, NH), 1.34 (d, 3H,
Ph), 86.71 (s, C5H5), 64.06 (s, NCHPh), 23.17 (s, CHMe)
ppm. 31P{1H} NMR (CD2Cl2/CDCl3): d 54.25 (s, PPh3)
ppm.
3J(HH) 6 Hz, CHCH3), 1.25 (s, 9H, Bu) ppm. 13C{1H}
NMR (CD2Cl2): d 139.68 (s, Cipso, Ph), 133.40 (d, J(PC)
44 Hz, Cipso, PPh3), 133.39 (d, 2J(PC) 11 Hz, Cortho
PPh3), 131.39 (s, Cpara, PPh3), 129.61 (d, J(PC) 10 Hz,
,
3
5.2.12. [(g5-C5H5)Ru(PPh3)(CNtBu)(NHEt2)]PF6 (9)
A Schlenk tube was charged with a solution of 1 (0.20 g,
0.37 mmol) in dichloromethane (30 ml), thallium hexaflu-
orophosphate (0.19 g, 0.54 mmol), and a magnetic stirrer
bar. The orange solution was stirred in the dark under
nitrogen at room temperature for 1 h to give a tomato-
orange suspension. Excess diethylamine (0.4 ml,
3.87 mmol) was added and the solution was stirred in the
dark at room temperature overnight. Filtration, evapora-
tion of the filtrate under reduced pressure, and crystalliza-
tion of the yellow residue from dichloromethane and
diethylether (1:3, 20 ml) at À30 ꢁC afforded orange-yellow
crystals of 9. Yield 0.16 g (60%).
Cmeta, PPh3), 129.08 (s, Cortho, Ph), 128.97 (s, Cpara, Ph),
127.85 (s, Cmeta, Ph), 82.18 (s, C5H5), 68.08 (s, NCHPh),
58.57 (s, CMe3), 45.70 (s, NHCH3), 30.48 (s, CMe3),
23.99 (s, CHMe) ppm. 31P{1H} NMR (CD2Cl2): d 58.3
(s, PPh3) ppm.
10SRS: 1H NMR (CD2Cl2): d 7.32–7.51 (m, 15H,
PPh3), 6.80 (m, 5H, Ph), 4.81 (s, 5H, C5H5), 3.88 (qd,
1H, 3J(HH) 7 Hz, 4J(PH) 1.8 Hz, NHCH), 2.51 (br.s,
3
1H, NHCH3), 2.23 (d, 3H, J(HH) 6 Hz, NHCH3), 1.55
(d, 3H, 3J(HH) 7 Hz, CHCH3), 1.30 (s, 9H, Bu) ppm.
13C{1H} NMR (CD2Cl2): d 139.41 (s, Cipso, Ph), 133.52
(d, J(PC) 44 Hz, Cipso, PPh3), 133.56 (d, 2J(PC) 10 Hz,
C
ortho, PPh3), 131.39 (s, Cpara, PPh3), 129.62 (d, 3J(PC)
IR (Nujol): mmax 3269w, 1613vw (NH), 2129m, 2062sh.w
9 Hz, Cmeta, PPh3), 129.64 (s, Cortho, Ph), 127.82 (s, Cpara
+
1
(CN), and 841s cmÀ1 (PF6). H NMR (CD2Cl2): d 7.26–
Cmeta, Ph), 82.44 (s, C5H5), 65.73 (s, NCHPh), 58.62 (s,
7.49 (m, 15H, PPh3), 4.78 (s, 5H, C5H5), 2.78 (m, 2H,
2,3J(HH) 7 Hz, CH2CH3), 2.67 (m, 2H, 2,3J(HH) 7 Hz,
CH2CH3), 1.68 (br.s, 1H, NH), 1.20 (s, 9H, CMe3), 1.08
(t, 3H, 2,3J(HH) 7 Hz, CH2CH3), 0.44 (t, 3H, 2,3J(HH)
7 Hz, CH2 CH3) ppm. 13C{1H} NMR (CD2Cl2): d 133.88
CMe3), 41.35 (s, NHCH3), 30.75 (s, CMe3), 24.80 (s,
CHMe) ppm. 31P{1H} NMR (CD2Cl2): d 58.1 (s, PPh3)
ppm.
1
10SSS: H NMR (CD2Cl2): d 6.15 (m, 5H, Ph), 4.83 (s,
3
5H, C5H5), 3.78 (q, 1H, J(HH) 7 Hz, NHCH), 2.51 (br.s,
2
3
(d, Cipso, PPh3), 133.37 (d, J(PC) 11 Hz, Cortho), 131.32
1H, NHCH3), 2.46 (d, 3H, J(HH) 6 Hz, NHCH3), 1.85
(s, Cpara), 129.52 (d, 3J(PC) 10 Hz, Cmeta), 82.08 (s,
C5H5), 58.45 (s, CMe3), 56.13, 51.54 (2s, CH2), 30.45 (s,
CMe3), 14.67, 14.08 (2s, CH3) ppm. 31P{1H} NMR
(CD2Cl2): d 58.3 (s, PPh3), À145.40 (septet, 1J(PF)
712 Hz, PF6) ppm. MS (FAB): 585 [M À PF6]+(15%),
512(100), 454(9), 429(37).
(br.s, 1H, NHCH3), 1.50 (d, 3H, J(HH) 7 Hz, CHCH3),
3
1.26 (s, 9H, Bu) ppm. 13C{1H} NMR (CD2Cl2): d 82.30
(s, C5H5), 60.79 (s, CMe3), 47.18 (s, NHCH3), 30.64 (s,
CMe3), 14.75 (s, CHMe) ppm. 31P{1H} NMR (CD2Cl2):
d 55.7 (s, PPh3) ppm.
10RRS: 1H NMR (CD2Cl2): d 6.65 (m, 5H, Ph), 4.74 (s,
5H, C5H5), 3.73 (qd, 1H, 3J(HH) 7 Hz, 4J(PH) 1.8 Hz,
NHCH), 2.53 (d, 3H, 3J(HH) 6 Hz, NHCH3), 1.40 (d,
3H, 3J(HH) 7 Hz, CHCH3), 1.18 (s, 9H, Bu) ppm.
13C{1H} NMR (CD2Cl2): d 81.65 (s, C5H5), 41.05 (s,
NHCH3), 30.36 (s, CMe3), 20.80 (s, CHMe) ppm.
5.2.13. [(g5-C5H5)Ru(PPh3)(CNtBu)(NH(Me)-
CHMePh)]PF6 (10)
A solution of 1 (0.20 g, 0.37 mmol) in dichloromethane
(30 ml) was treated with thallium hexafluorophosphate